Abstract:Objective To establish a docetaxel-induced human breast carcinoma drug-resistant cell line BT549/docetaxel and explore the multidrug resistance gene adenosine triphosphate binding cassette transporter G2 (ABCG2),adenosine triphosphate binding cassette subfamily B member 1 (ABCB1),multidrug resistance associated protein 1 (ABCC1),glutathione S-transferase-π (GST-π),dihydmfolate reductase (DHFR),topoisomerase Ⅱ (Topo Ⅱ) and β-tubulin Ⅲ (TUBB3) genes expression and significance.Methods The drug-resistant cell line BT549/docetaxel was established in culture by exposing BT549 parent cells to moderate concentration of docetaxel over several months,The resistant index to docetaxel was determined by the methyl thiazolyl tetrazolium (MTT) assay,Cell colony formation was used to determine the sensitivity of BT549/docetaxel to docetaxel.HPLC was used to determine the intracellular concentration of docetaxel.Reverse transcriptase-polymerase chain reaction (RT-PCR) was used m detect the expression of ABCG2,ABCB1,ABCC1,GST-π,DHFR,Topo Ⅱ and TUBB3 genes in BT549/docetaxel cells.Results The resistant index of BT549/docetaxel was 18,3,Cryopreservation had no significant effect on the characteristics of anti-tumor drug resistance of BT549/docetaxel,After being cultured in RPMI 1640 without docetaxel for a period of 1 month,BT549/docetaxel showed a decrease in the resistant index,The BT549/docetaxel cells were 18.1 times more resistant to docetaxel and also demonstrated crossresistance to cisplatin,5-fluorouracil,cyclophosphamide and other anticancer drugs to some extent,The concentration of docetaxel in BT549/doeetaxel cells was lower than that in BT549 cells.In BT549/docetaxel cells,the expression levels of ABCG2,ABCB1,ABCC1,GST-π and TUBB3 genes were 0.97 ±0.15,0.75 ±0.13,0.77 ±0.14,1.49 ±0.31 and 1.52 ±0.22,significantly higher than those in BT549 cells (0.45 ±0.19,0.37 ±0.12,0.33 ±0.11,0.76 ±0.33,and 0.33 ±0.21,P ＜0.05 for all).Conclusion A stable human breast docetaxel resistant cell line BT549/docetaxel was successfully established.Its resistance mechanism may be related with the up-regulation of ABCG2,ABCB1,ABCC1,GST-π and TUBB3 genes. Key words: Docetaxel; Drug resistance; Breast cancer

Epithelial-mesenchymal Transition Contributes to Docetaxel Resistance in Human Non-Small Cell Lung Cancer.

Epithelial - mesenchymal transition contributes to human non - small lung cancer cell line A549 docetaxel resistance

Inhibition of ZEB1 Reverses EMT and Chemoresistance in Docetaxel-Resistant Human Lung Adenocarcinoma Cell Line.

Establishment and Characterization of a Docetaxel-Resistant Variant of Human Lung Adenocarcinoma Cell Line SPC-A1

Establishment and Characterization of a Docetaxel-Resistant Human Prostate Cancer Cell Line.

Long Noncoding Rna Ror Regulates Chemoresistance In Docetaxel-Resistant Lung Adenocarcinoma Cells Via Epithelial Mesenchymal Transition Pathway

Mechanism of Drug Resistance Identified in Human Lung Adenocarcinoma Cell Line SPC-A1 Selected for Resistance to Docetaxel

Long Noncoding RNA CCAT1 Acts As an Oncogene and Promotes Chemoresistance in Docetaxel-Resistant Lung Adenocarcinoma Cells.

Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition.

Identification of ING 4 ( Inhibitor of Growth 4 ) as a Modulator of Docetaxel Sensitivity in Human Lung Adenocarcinoma

[Research Progress of the Role of EMT in EGFR-TKIs Resistance of Non-small Cell Lung Cancer].

Establishment and biological characteristics of Taxol-induced drug resistant human lung adenocarcinoma cell line

The effects of cetuximab in combination with docetaxel for the acquired resistance to EGFR-TKI in non-small cell lung cancer cells

A Mirna-200C/cathepsin L Feedback Loop Determines Paclitaxel Resistance in Human Lung Cancer A549 Cells in Vitro Through Regulating Epithelial–mesenchymal Transition

The Gelatinases-Stimuli Nanoparticles Reverse Docetaxel Resistance and Epithelial to Mesenchymal Transition in Lung Cancer Cell Line

MicroRNA-451 Induces Epithelial–mesenchymal Transition in Docetaxel-Resistant Lung Adenocarcinoma Cells by Targeting Proto-Oncogene C-Myc

Acquisition of Docetaxel Resistance in Breast Cancer Cells Reveals Upregulation of ABCB1 Expression As a Key Mediator of Resistance Accompanied by Discrete Upregulation of Other Specific Genes and Pathways

Establishment of a Docetaxel-Induced Human Breast Carcinoma Drug-Resistant Cell Line MCF7/docetaxel and Its Biological Characteristics

Identification of Microrna Profiles in Docetaxel-Resistant Human Non-Small Cell Lung Carcinoma Cells (SPC-A1)

Establishment of a docetaxel-induced human breast carcinoma drug-resistant cell line BT549/docetaxel and the mRNA expression of adenosine triphosphate binding cassette transporter G2, adenosine triphosphate binding cassette subfamily B member 1, multidrug